1910 Genetics Launches CANDID-CNS™, an AI Model for Blood-Brain Barrier Permeability Prediction 1910 Genetics, a biotechnology company specializing in small and large molecule drug discovery, has announced the launch of CANDID-CNS™, an AI model designed to predict blood-brain barrier (BBB)…
Alterome Therapeutics, Inc. Recognized at Goldman Sachs Builders and Innovators Summit Alterome Therapeutics, Inc., a biopharmaceutical company specializing in next-generation small molecule targeted therapies for cancer, announced that Eric Murphy, Ph.D., CEO and co-founder, was honored as one of the…
iProov Reports 63% Transaction Growth Amid Rising Demand for Biometric Solutions iProov, a leader in biometric identity solutions, announced a remarkable 63% increase in transaction volume on its platform from August 2023 to August 2024. This surge reflects a growing…
Sage Therapeutics, Inc. (Nasdaq: SAGE) has unveiled a strategic reorganization initiative aimed at prioritizing the commercialization of ZURZUVAE® for postpartum depression while sharpening its focus on pipeline development, including the upcoming clinical study for dalzanemdor in Huntington’s Disease, slated for…
Artesunate AMIVAS, the first fully licensed treatment for severe malaria in Europe, is now available for purchase across Europe and the U.K. through Nordic Prime in Denmark. Approved by the European Commission and the U.K.’s Medicines and Healthcare products Regulatory…
WuXi Biologics (“WuXi Bio”) (2269.HK), a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO), announced its fourth consecutive Platinum Award from The Asset ESG (Environmental, Social, and Governance) Corporate Awards. This recognition highlights the company’s dedication to sustainable…
Alnylam Submits Type II Variation to EMA for Vutrisiran in ATTR Amyloidosis with Cardiomyopathy CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 16, 2024—Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced the submission of a Type II Variation to the European Medicines Agency (EMA) for vutrisiran, an…
The Women’s Brain Foundation and Medscape Education Launch Learning Center on Sex and Gender in Brain Health The Women’s Brain Foundation (WBF), a leader in integrating sex- and gender-based research in healthcare since 2017, has partnered with Medscape Education, a…
Sensorion to Present GJB2-GT Research at ESGCT Congress 2024 Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of innovative therapies for hearing loss, has announced its participation in the 31st Congress of the European Society…
Insights on Consumer Attitudes Toward Healthy, Sustainable Food Systems The FoodMinds 2024 Conscious Consumption Index (CCI) reveals a growing awareness of healthy and sustainable food systems among consumers. Despite this awareness, less than half (42%) of surveyed individuals report purchasing…
Nielsen IQ (NIQ), the leading consumer research and retail monitoring firm, has unveiled its mid-year Consumer Outlook report, revealing a significant shift in Asia-Pacific consumer behavior towards purposeful consumption. This trend mirrors a global movement as consumers become more conscious…
As CarePlus celebrates its 25th anniversary, the Florida-based Medicare Advantage provider is enhancing its plans for 2025, focusing on affordable healthcare and financial wellness. The new offerings aim to improve health outcomes across the state, featuring robust subsidies, $0 copays,…